Perspective Therapeutics (CATX) Operating Leases (2019 - 2026)
Perspective Therapeutics' Operating Leases history spans 8 years, with the latest figure at $1.6 million for Q1 2026.
- On a quarterly basis, Operating Leases rose 32.2% to $1.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $1.6 million, a 32.2% increase, with the full-year FY2025 number at $1.0 million, down 29.62% from a year prior.
- Operating Leases hit $1.6 million in Q1 2026 for Perspective Therapeutics, up from $1.0 million in the prior quarter.
- Over the last five years, Operating Leases for CATX hit a ceiling of $1.7 million in Q3 2024 and a floor of $44000.0 in Q1 2023.
- Historically, Operating Leases has averaged $941625.0 across 5 years, with a median of $1.0 million in 2024.
- Biggest five-year swings in Operating Leases: crashed 86.42% in 2023 and later soared 2256.82% in 2024.
- Tracing CATX's Operating Leases over 5 years: stood at $186000.0 in 2022, then soared by 319.35% to $780000.0 in 2023, then soared by 83.08% to $1.4 million in 2024, then decreased by 29.62% to $1.0 million in 2025, then skyrocketed by 54.43% to $1.6 million in 2026.
- Business Quant data shows Operating Leases for CATX at $1.6 million in Q1 2026, $1.0 million in Q4 2025, and $971000.0 in Q3 2025.